Sort   by:  
 Page size 
UnknownAnti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
Not available
S-EPMC5372253 | biostudies-literature
UnknownPyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.
Not available
S-EPMC8999016 | biostudies-literature
UnknownPreoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma.
Not available
S-EPMC6240848 | biostudies-literature
UnknownClinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scores.
Not available
S-EPMC8358417 | biostudies-literature
UnknownClinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.
Not available
S-EPMC8113298 | biostudies-literature
UnknownChange in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the Netherlands.
Not available
S-EPMC11966110 | biostudies-literature
UnknownPredictors of adherence to exercise interventions during and after cancer treatment: A systematic review.
Not available
S-EPMC5887924 | biostudies-literature
UnknownA methodology to systematically analyze the hospital discharge of terminally ill patients.
Not available
S-EPMC6257431 | biostudies-literature
UnknownPhase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.
Not available
S-EPMC7497683 | biostudies-literature
UnknownRobust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines.
Not available
S-EPMC8474886 | biostudies-literature
Sort   by:  
 Page size